BioCatalyst

TYRA-300 — catalyst calendar

1 verified catalyst event(s) referencing TYRA-300, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Ca
Phase 1/2 · Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma
 TYRA Tyra Biosciences, Inc. TYRA-300 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.